Previous 10 | Next 10 |
home / stock / sdmhf / sdmhf news
Sartorius Stedim Biotech closes acquisition of BIA Separations - Combination of businesses creates a premium portfolio for advanced therapies - Course set for successful integration PR Newswire AUBAGNE, France, Nov. 2, 2020 AUBAGNE, France , Nov. 2, 202...
Sartorius Stedim Biotech S.A. (SDMHF): Q3 GAAP EPS of €3.02.Revenue of €1.38B (+27.8% Y/Y).The company now expects FY2020 consolidated sales revenue to increase at the upper end of, or slightly above, the range of 26% 30% and underlying EBITDA margin to be around ...
Strong profitable growth at Sartorius Stedim Biotech - Nine-months results: Sales revenue 1,379.4 million euros; underlying EBITDA1 margin climbs to 31.5 percent - High growth across all product categories and geographies - Management specifies financial guidance at the ...
The following slide deck was published by Sartorius Stedim Biotech S.A. in conjunction with their 2020 Q2 earnings Read more ...
AUBAGNE, France , July 21, 2020 /PRNewswire/ -- Based on dynamic business performance in the first six months of 2020 and on expectations that demand will remain high for the rest of the year, Sartorius Stedim Biotech, a leading partner of the biopharma industry, raised its growth an...
AUBAGNE, France , June 24, 2020 /PRNewswire/ -- At the virtual combined Annual General Shareholders' Meeting (ASM) of Sartorius Stedim Biotech S.A., shareholders passed the resolution to pay a dividend of €0.34 per share for fiscal 2019. The previous year's dividend was Ȋ...
GÖTTINGEN, Germany , April 30, 2020 /PRNewswire/ -- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, successfully closed the acquisition of selected life science businesses of Danaher Corporation. The transaction was completed on...
AUBAGNE, France , April 21, 2020 /PRNewswire/ -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, has continued on its profitable growth track in the first quarter 2020 despite uncertainties and challenges arising from the coronavirus pandemic. The Group grew b...
AUBAGNE, France , March 20, 2020 /PRNewswire/ -- On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher life science businesses by Sartorius, SSB's major shareholder. Both approvals ...
AUBAGNE, France , Feb. 18, 2020 /PRNewswire/ -- Group sales revenue up 17.0% in constant currencies; underlying EBITDA margin (1) up 1.1 percentage point to 29.3% Dividend proposal of 0.68 euros per share Positive outlook for 2020: Sales revenue expected to rise 11% to 14% in ...
News, Short Squeeze, Breakout and More Instantly...
Sartorius Stedim Biotech Company Name:
SDMHF Stock Symbol:
OTCMKTS Market:
Nine-month results 2022 of Sartorius Stedim Biotech PR Newswire Sales revenue up 17.0 percent in constant currencies, underlying EBITDA margin at 35.0 percent Overall market situation characterized by innovations and strong growth drivers; current development as ex...
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions PR Newswire UK-based Albumedix Ltd. is a leader in the field of recombinant albumin-based solutions and a highly innovative and profitable company Re...
Half-year results 2022 of Sartorius Stedim Biotech PR Newswire AUBAGNE, France , July 21, 2022 Sales revenue up 22.1 percent in constant currencies, underlying EBITDA margin 35.2 percent 2022 outlook confirmed: Sales revenue expected...